Scientific study suggests that mesoporous silica particles (MSPs) interact with the lipid digestion and absorption pathways to reduce calorific uptake
Stockholm, March 21[st], 2022: Sigrid Therapeutics today announced the publication of a multifaceted, scientific study in the peer-reviewed journal European Journal of Pharmaceutics and Biopharmaceutics suggesting that interactions between micron-sized mesoporous silica particles (MSPs), lipid digestion and absorption pathways are a likely mechanism for reducing calorific uptake. The results are compatible with previous findings that the mode of action for MSPs acting as “molecular sieves” block food enzyme activity.Several previous studies, both in animals and in man, have shown promising